Congress Asset Management CO Novo Nordisk A S Transaction History

Congress Asset Management CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 07, 2019	SELL	$46.79 - $52.47 $318,172 - $356,796	-6,800 Closed	0 $0
Q1 2019 May 08, 2019	SELL	$46.36 - $52.63 $6,814 - $7,736	-147 Reduced 2.12%	6,800 $356,000
Q3 2018 Oct 26, 2018	BUY	$46.76 - $51.24 $6,873 - $7,532	147 Added 2.16%	6,947 $327,000
Q3 2017 Oct 17, 2017	BUY	$41.15 - $49.22 $279,820 - $334,696	6,800	6,800 $327,000

1,955

318M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $193B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Congress Asset Management CO , based on Form 13F filings with the SEC.

Stay updated on Congress Asset Management CO with notifications on news.